Ardsley Advisory Partners LP Purchases 50,000 Shares of Surgery Partners, Inc. $SGRY

Ardsley Advisory Partners LP boosted its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 20.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 300,000 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Ardsley Advisory Partners LP owned 0.23% of Surgery Partners worth $6,669,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Natixis Advisors LLC acquired a new position in shares of Surgery Partners during the first quarter worth approximately $292,000. PNC Financial Services Group Inc. increased its stake in Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after purchasing an additional 542 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Surgery Partners by 6.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 890,816 shares of the company’s stock worth $21,157,000 after buying an additional 56,399 shares during the last quarter. Nuveen LLC acquired a new position in Surgery Partners during the first quarter worth $7,496,000. Finally, Russell Investments Group Ltd. lifted its stake in shares of Surgery Partners by 241.0% in the first quarter. Russell Investments Group Ltd. now owns 21,257 shares of the company’s stock valued at $505,000 after buying an additional 15,024 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have recently commented on SGRY. Royal Bank Of Canada decreased their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Cantor Fitzgerald reiterated an “overweight” rating and set a $36.00 price target on shares of Surgery Partners in a research note on Tuesday, October 7th. JPMorgan Chase & Co. lowered their price objective on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a research note on Monday, November 24th. Weiss Ratings restated a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, November 24th. Finally, UBS Group cut their target price on Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, November 13th. Seven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $27.44.

Surgery Partners Trading Up 4.1%

NASDAQ:SGRY opened at $17.41 on Wednesday. Surgery Partners, Inc. has a 52 week low of $14.94 and a 52 week high of $26.16. The firm has a 50-day moving average price of $19.14 and a two-hundred day moving average price of $21.18. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. The firm has a market cap of $2.25 billion, a price-to-earnings ratio of -12.80 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, November 10th. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The business had revenue of $821.50 million during the quarter, compared to analysts’ expectations of $823.55 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.Surgery Partners’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.19 EPS. On average, equities analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.